ARCHIVES

FDA Approves Cyramza for Stomach Cancer; Zykadia in NSCLC; Lipiodol for HCC Imaging; And Cobas HPV Test for Primary Screening

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

IOM Committee Will Probe Duke Scandal Together With Other “Omics” Case Studies

January 7, 2011

In a letter, ASCO reaffirms its views on oncology consolidation at FDA.

July 9, 2004

NIH Biennial Report Offers Research Portrait

September 24, 2010

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

July 26, 2013

Editorial: Ambiance Through Exclusion

May 20, 1994

Senate Passes NIH Reauthorization 87-10; $2.5 Bil. Auhtority For NCI, New Line Items

April 10, 1992